Mathieu Fradet

发表

Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet’s signaling cascades as new outcome measures in clinical trials

J. Dubé, F. Corbin, D. Pellerin, 2016, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.